Who are Quotient Sciences?
35+ Year History of Excellence
Bringing decades of integrated CRDMO experience covering drug product formulation development for Phase 1 trials, through commercial drug product manufacturing.
Innovating drug development
Translational Pharmaceutics®, our flagship platform, integrates capabilities typically spread across multiple CROs and CDMOs to support faster innovation.
Global drug development expertise
Clinical testing and drug product manufacturing facilities in the UK and US, inspected and approved by leading global regulatory authorities.
Let's explore development strategies.
As a leading CRDMO small molecule manufacturing, with diverse capabilities in early phase clinical research and drug product manufacturing, Quotient Sciences can help you advance your therapy with confidence.
Connect with our multidisciplinary team to start a tailored discussion about drug development, early clinical testing, scale‑up, or manufacturing support for your next drug program.
A CRDMO is a contract research, development, and manufacturing organization. A company that offers CRDMO services integrates different areas that would typically be found by selecting multiple vendors.
Yes, Quotient Sciences is a CRDMO. From facilities located in the US and UK, Quotient Sciences offers coordinated contract research, development, and manufacturing services (CRO services and CDMO services) as part of one organization.
Contract research and manufacturing services are often separate services. Simply put, a company that offers CRDMO services integrates different areas that would typically be found by selecting multiple vendors.
A CRDMO offers a contract research, development, and manufacturing as part of one organization.
Contract research and manufacturing services are often separate services. Simply put, a company that offers CRDMO services integrates different areas that would typically be found by selecting multiple vendors. A CRDMO offers a contract research, development, and manufacturing as part of one organization.